Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The Board of Directors' decisions held on 13/05/2025.
The BoD Decisions (299 KB)
The BoD Report (1,648 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The Board of Directors' decisions held on 13/05/2025.
The BoD Decisions (299 KB)
The BoD Report (1,648 KB)
Comments